FDA approves Restylane Lyft for cheek augmentation- Galderma

Galderma announced that it has received FDA approval to market Restylane Lyft for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.

Restylane Lyft, formerly marketed as Perlane-L, is an injectable gel used to increase volume and smooth wrinkles in the face. With this new indication, Restylane Lyft is the first FDA-approved filler indicated to provide fullness to the midface area (cheeks) and to correct and smooth the nasolabial folds ("smile lines"). Restylane Lyft joins Restylane, indicated to correct and smooth smile lines as well as to augment the lips, and Restylane Silk, the first treatment approved for lip enhancement and the treatment of wrinkles and lines around the mouth.